FDA approves first companion diagnostic test to screen multiple non-small cell lung cancer therapies

The U.S. FDA has granted premarket approval to Thermo Fisher Scientific for the first NGS -based test that simultaneously screens tumor samples for biomarkers associated with three FDA-approved therapies for non-small cell lung cancer (NSCLC).

PerkinElmer to Acquire EUROIMMUN Medical Laboratory Diagnostics AG

PerkinElmer, Inc announced that it has entered into a definitive agreement to acquire EUROIMMUN Medical Laboratory Diagnostics AG. The agreement provides that PerkinElmer will acquire up to a 100% stake in EUROIMMUN.

Swedish healthcare provider selects Sectras digital pathology solution for diagnostics Systems

International medical imaging IT and cybersecurity company Sectra announces that Vasternorrland County Council, in Sweden, orders Sectra solution for storing and reviewing digital pathology images.

The right climate conditions for the NICU

Babies are warm and cozy in the amniotic sac where they can float nearly weightlessly. External stimuli are cushioned, and the tiny body only perceives them slightly. A mother womb cannot be replaced. Medical technology has, however, advanced continuously...

Modernizing Medicine Announces Agreement With Covermymeds For Electronic Prior Authorization

CoverMyMeds, a leader in electronic prior authorization (ePA) solutions, and Modernizing Medicine, the specialty-specific health IT leader, announced an agreement to bring electronic prior...

Janssen Biotech announces US FDA approval of DARZALEX

Janssen Biotech, Inc. announced that the U.S. FDA has approved the immunotherapy DARZALEX (daratumumab) in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least...